Pfizer is currently assessing the potential divestiture of its hospital drugs unit, a division mainly focused on antibiotics ...

Last month, the company sold a stake of approximately $3.26bn in Haleon, a UK-based consumer healthcare group. These strategic moves come as Pfizer, under the leadership of CEO Albert Bourla ...

Haleon said in a prospectus filed earlier this week that it could face "possible liabilities" connected with OTC Zantac, although it is in the midst of indemnity negotiations with GSK and Pfizer ...

05:45 BlackRock increases stake in Waterford-based Panadol maker Haleon 05:00 Eithne Shortall: The merits of election posters are debatable, but on balance, I’m in favour of them 05:00 Ashbourne’s Fox ...

A multimillion-pound legal battle between rival developers of Covid-19 jabs over vaccine technology patents is set to ... Subscribe now to see this Premium News article from Alliance News ...

Meenakshi Nevatia, Managing Director of Pfizer Limited on Tuesday said that the company is planning to expand its manufacturing capacity and it is focusing on research and development. Nevatia ...

UBS analyst Trung Huynh maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $31.00. The company’s shares closed yesterday at $26.72. Huynh covers the ...

Bank of America Securities analyst Victoria Petrova has maintained their bullish stance on HLN stock, giving a Buy rating on November 4.